Submitted by Anonymous (not verified) on 28 May 2025 - 14:30
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 23, Status: Authorised